Ipswich Investment Management »

Crispr Therapeutics shares owned by Ipswich Investment Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Ipswich Investment Management from 13F filings

Historical chart of Ipswich Investment Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Ipswich Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Ipswich Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 25k 46.98
2024-06-30 $1.3M 24k 54.01
2024-03-31 $1.7M 25k 68.16
2023-12-31 $1.5M 24k 62.60
2023-09-30 $1.1M 24k 45.39
2023-06-30 $1.3M 24k 56.14
2023-03-31 $1.1M 24k 45.23
2022-12-31 $995k 25k 40.65
2022-09-30 $1.6M 25k 65.34
2022-06-30 $1.6M 26k 60.78
2022-03-31 $1.7M 26k 62.79
2021-12-31 $2.0M 27k 75.77
2021-09-30 $3.1M 28k 111.94
2021-06-30 $4.4M 27k 161.89
2021-03-31 $3.3M 27k 121.86
2020-12-31 $4.4M 29k 153.11
2020-09-30 $2.6M 31k 83.65
2020-06-30 $2.9M 39k 73.50
2020-03-31 $1.7M 41k 42.41
2019-12-31 $2.6M 43k 60.92
2019-09-30 $1.8M 44k 40.98
2019-06-30 $2.1M 44k 47.09
2019-03-31 $1.6M 44k 35.72
2018-12-31 $1.3M 45k 28.57
2018-09-30 $2.1M 46k 44.35
2018-06-30 $3.4M 57k 58.76
2018-03-31 $2.6M 57k 45.71
2017-12-31 $1.1M 48k 23.48